(Q38158442)

29 August 2017

Zika enhancement: a reality check (English)

1 reference

29 August 2017

0 references

2

Mauro M Teixeira

1 reference

29 August 2017

1

Suresh Mahalingam

1 reference

29 August 2017

Scott B Halstead

3

1 reference

29 August 2017

21 June 2017

1 reference

29 August 2017

3

1 reference

Lancet Infectious Diseases

inferred from page(s)

published in

1 reference

29 August 2017

17

1 reference

29 August 2017

686-688

1 reference

29 August 2017

7

1 reference

PubMed ID

28653626

on focus list of Wikimedia project

29 August 2017

WikiProject Zika Corpus

0 references

cites work

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Neutralization and antibody-dependent enhancement of dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Effect of age on outcome of secondary dengue 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Zika-induced antibody response enhances dengue serotype 2 replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

Zika virus infection, associated microcephaly, and low yellow fever vaccination coverage in Brazil: is there any causal link?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930340-7

7 January 2021

10.1016/S1473-3099(17)30340-7

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

28653626